Effect of growth hormone on height, weight, and body composition in Prader-Willi syndrome

P S Davies1, S Evans, S Broomhead

  • 1School of Human Movement Studies, Faculty of Health, Queensland University of Technology, Brisbane, Australia.

Insights

Growth hormone treatment in children with Prader-Willi syndrome significantly reduced body fat and increased height velocity. Further trials are recommended to explore optimal dosages for this condition.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Growth Hormone Therapy

Background:

  • Prader-Willi syndrome is a complex genetic disorder affecting multiple body systems.
  • Children with Prader-Willi syndrome often exhibit growth deficiencies and abnormal body composition.

Purpose of the Study:

  • To assess the impact of growth hormone (GH) administration on stature, body weight, and body composition in children with Prader-Willi syndrome.
  • To evaluate changes in anthropometric measurements and body fat percentage following GH treatment.

Main Methods:

  • A study involving 25 children aged 4-10 years with Prader-Willi syndrome.
  • Measurements of height, weight, and skinfold thickness recorded at baseline and after six months of daily subcutaneous GH injections.
  • Body composition assessed using total body water measurements with stable isotopes.

Main Results:

  • Significant reduction in body fat percentage observed post-GH treatment.
  • Height velocity doubled during the six-month treatment period.
  • Body weight SDS remained unchanged, while skinfold thickness decreased significantly.

Conclusions:

  • Growth hormone treatment shows promising benefits for children with Prader-Willi syndrome.
  • Results support further prolonged trials and investigation into varied GH dosage regimens.
  • GH therapy may be a valuable intervention for improving body composition and growth in this population.
Abstract

Related Concept Videos

Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...